HB3710 EngrossedLRB103 27320 CPF 53691 b HB3710 Engrossed LRB103 27320 CPF 53691 b
HB3710 Engrossed LRB103 27320 CPF 53691 b
1 AN ACT concerning health.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 1. Short title. This Act may be cited as the
5 Alternative Protein Innovation Task Force Act.
6 Section 5. Definitions. As used in this Act:
7 "Alternative proteins" means proteins created from
8 plant-based, fermented, cell-cultured inputs and processes to
9 create foods that share sensory characteristics with
10 conventional meat and dairy.
11 "Cultivated meat" means meat that is produced in a
12 bioreactor from animal cells using a cell cultivation process.
13 "Fermented protein" means a protein that is made from
14 traditional fermentation, biomass fermentation, or precision
15 fermentation.
16 "Plant-based protein" means a protein that is produced
17 directly from a plant.
18 Section 10. Alternative Protein Innovation Task Force. The
19 Alternative Protein Innovation Task Force is established for
20 the purposes of investigating and studying alternative
21 proteins and developing a master plan of recommendations for
22 fostering the appropriate expansion of protein innovation and
HB3710 Engrossed LRB103 27320 CPF 53691 b
HB3710 Engrossed- 2 -LRB103 27320 CPF 53691 b HB3710 Engrossed - 2 - LRB103 27320 CPF 53691 b
HB3710 Engrossed - 2 - LRB103 27320 CPF 53691 b
1 the alternative protein industry in the State. The Task Force
2 shall study how the State can best support the growing
3 alternative protein industry in the State. The Task Force
4 shall: (i) examine the potential economic development benefits
5 and job creation potential of the plant-based protein,
6 cultivated meat, and fermented protein industries in the
7 State; (ii) identify the environmental benefits of alternative
8 proteins; (iii) examine how alternative proteins can
9 strengthen the State's food resilience; (iv) assess how
10 alternative proteins can improve individual health, public
11 health, and food security in the State; and (v) identify ways
12 the State can foster the growth of the emerging alternative
13 protein industry, including by reviewing past efforts made to
14 support the broader biotech and life science industries.
15 Section 15. Membership; appointments; meeting.
16 (a) The Alternative Protein Innovation Task Force shall
17 consist of the following members:
18 (1) one member of the Senate, who shall be appointed
19 by the President of the Senate and shall serve as co-chair
20 of the Task Force;
21 (2) one member of the Senate, who shall be appointed
22 by the Minority Leader of the Senate;
23 (3) one member of the House of Representatives, who
24 shall be appointed by the Speaker of the House of
25 Representatives and shall serve as co-chair of the Task
HB3710 Engrossed - 2 - LRB103 27320 CPF 53691 b
HB3710 Engrossed- 3 -LRB103 27320 CPF 53691 b HB3710 Engrossed - 3 - LRB103 27320 CPF 53691 b
HB3710 Engrossed - 3 - LRB103 27320 CPF 53691 b
1 Force;
2 (4) one member of the House of Representatives, who
3 shall be appointed by the Minority Leader of the House of
4 Representatives;
5 (5) the Secretary of Commerce and Economic Opportunity
6 or the Secretary's designee;
7 (6) the Director of Agriculture or the Director's
8 designee;
9 (7) 2 members who are appointed by the Director of
10 Agriculture and are commercial producers of agricultural
11 commodities; and
12 (8) 7 members who are appointed by the Governor. Of
13 the members appointed by the Governor, 2 members shall be
14 engaged in academic or scientific research on alternative
15 protein development at a State college or university; one
16 member shall be engaged in the private sector research and
17 development of alternative proteins; one member shall be
18 an academic expert in food security issues of the State;
19 one member shall be a representative of a nonprofit
20 organization dedicated to the development and
21 accessibility of alternative proteins; one member shall be
22 a representative of the State's agricultural biotechnology
23 industry; and one member shall be the president of the
24 Illinois Biotechnology Industry Organization or the
25 organization's designee.
26 (b) Members of the Task Force shall not receive
HB3710 Engrossed - 3 - LRB103 27320 CPF 53691 b
HB3710 Engrossed- 4 -LRB103 27320 CPF 53691 b HB3710 Engrossed - 4 - LRB103 27320 CPF 53691 b
HB3710 Engrossed - 4 - LRB103 27320 CPF 53691 b
1 compensation for their services to the Task Force.
2 (c) All appointments shall be made not later than 30 days
3 after the effective date of this Act.
4 (d) The co-chairs of the Task Force shall schedule no
5 fewer than 4 meetings of the Task Force, including not less
6 than one public hearing. The co-chairs shall convene the first
7 meeting of the Task Force within 60 days after the effective
8 date of this Act.
9 Section 20. Report.
10 (a) The Task Force shall study and analyze the potential
11 benefits of alternative proteins and shall address in its
12 report:
13 (1) the job growth potential of the alternative
14 protein industry in the State as demand for protein
15 continues to grow;
16 (2) how plant-based protein, fermented proteins, and
17 cultivated meat can yield environmental benefits;
18 (3) how the State can support new and emerging
19 companies in this sector and what pressing challenges the
20 industry currently faces;
21 (4) policy options the State can consider taking to
22 address the needs of the alternative protein industry;
23 (5) actions that can be taken to facilitate the growth
24 of the alternative protein industry; and
25 (6) any other topic that the Task Force may choose to
HB3710 Engrossed - 4 - LRB103 27320 CPF 53691 b
HB3710 Engrossed- 5 -LRB103 27320 CPF 53691 b HB3710 Engrossed - 5 - LRB103 27320 CPF 53691 b
HB3710 Engrossed - 5 - LRB103 27320 CPF 53691 b
1 examine in relation to alternative proteins.
2 (b) The Task Force shall submit a report of its findings
3 and recommendations to the General Assembly, together with
4 drafts of proposed legislation necessary to carry out those
5 recommendations, not later than December 31, 2023.
HB3710 Engrossed - 5 - LRB103 27320 CPF 53691 b